ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, today announced it has been named the Health IT Innovator of the Year by the Pittsburgh Technology Council.
ERT has been recognized for its suite of innovative clinical trial solutions that pharmaceutical researchers rely on to determine the safety and effectiveness of new medical treatments. The award was presented on September 25 during the annual Tech 50 Gala.
The Tech 50 Awards program recognizes the companies that are impacting their customers and driving the success of the Pittsburgh region ─ and the industry at large ─ through innovative ideas and state-of-the-art technologies.
ERT’s electronic Clinical Outcome Assessment (eCOA), Cardiac Safety, Respiratory, Imaging, Real World Evidence and Trial Oversight solutions improve clinical trial efficiencies, overcome the limitations of traditional paper-driven approaches, and deliver the highest quality patient data so it’s biopharmaceutical customers can accelerate clinical development, getting novel treatments to patients sooner. ERT’s eClinical solutions have been used in the development of more than half of all drugs approved by the FDA since 2013.
“We’re very honored and grateful to the Tech 50 judging panel for identifying ERT among a crowded field of innovative companies in the Pittsburgh region,” said Jim Corrigan, President and CEO, ERT. “This award really represents the hard work our employees do every day – in Pittsburgh, and around the globe ─ and their commitment to delivering the solutions and services our customers rely on as they develop new medical treatments for patients worldwide.”
For more information on ERT’s suite of eClinical solutions, visit ert.com.